Clinical Trial/Study

Heart Valve Repair

Neovasc Inc. has received conditional Investigational Device Exemption (IDE) approval from the U.S. FDA to initiate the U.S. arm of its Tiara-I Early Feasibility Trial for the company's Tiara transcatheter mitral valve. The Tiara-I Early Feas...

October 8, 2014 — Abbott announced the start of the ABSORB IV clinical trial, which will test whether the Absorb bioresorbable vascular scaffold (BVS) is more cost effective and offers a higher quality of life than a best-in-class, permanent,...

Boston Scientific Corp. has initiated the REPRISE III clinical trial, a pivotal study to evaluate the safety and effectiveness of the Lotus valve system in patients with severe aortic stenosis and who are considered to be at either high or extreme...

September 26, 2014 — In response to new science showing that complete revascularization of all significantly blocked arteries leads to better outcomes in some heart attack patients, the American College of Cardiology (ACC) has withdrawn its Choosi...

CardioDx Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the presentation of the study, "The Use of a Gene...
October 20, 2014 — Boston Scientific Corp. has initiated the PLATINUM Diversity trial to evaluate the clinical performance of the Promus Premier...
Sunshine Heart Inc. today announced the results of its feasibility study entitled “Ambulatory Extra-Aortic Counterpulsation in Patients with Moderate to...
Neovasc Inc. has received conditional Investigational Device Exemption (IDE) approval from the U.S. FDA to initiate the U.S. arm of its Tiara-I Early...
Covidien DEFINITIVE LE Study Peripheral Artery Disease
The Solitaire Flow Restoration Device from Covidien is among a new generation of devices designed to remove blood clots from blocked brain...
Tilda, Vigila and Celerity leads offer a complete package for physicians to better manage their patients’ individualized needs. Tilda...
The U.S. Food and Drug Administration (FDA) in April 2012 approved an expanded indication for Medtronic’s cardiac resynchronization therapy...

Articles

Neovasc Inc. has received conditional Investigational Device Exemption (IDE) approval from the U.S. FDA to initiate the U.S. arm of its Tiara-I Early...
Imricor Medical Systems, Inc. announced the first three cardiac ablation procedures were completed in the first clinical study that is evaluating the...
Impact of Mental Stress on Heart Varies Between Men, Women ACC Study
Men and women have different cardiovascular and psychological reactions to mental stress, according to a study of men and women who were already being treated...
October 8, 2014 — New updates to the Society for Cardiovascular Angiography and Interventions (SCAI) appropriate use criteria (AUC) calculator tool will help...

Video Center

By Dave Fornell, editor of DAIC Magazine The key take away messages from the 26th annual...
3 weeks 5 days ago
As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
7 weeks 8 hours ago
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
12 weeks 5 days ago
This webinar will discuss why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient...
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...

Comparison Charts

Sorry there is no data available